Optogenetic insights into striatal function and behavior

Behavioural Brain Research

Volumn 255, Issue , 2013, Pages 44-54

  Lenz, Jeffrey D ^a   Lobo, Mary Kay ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Medium spiny neurons; Motor Control; Optogenetics; Reward; Striatum; Tonically active cholinergic interneurons

Indexed keywords

COCAINE; G PROTEIN COUPLED RECEPTOR; RAC1 PROTEIN;

BASAL GANGLION; BEHAVIOR; BRAIN FUNCTION; BRAIN NERVE CELL; CORPUS STRIATUM; DEPRESSION; DRUG DEPENDENCE; HUMAN; HUNTINGTON CHOREA; INTERNEURON; MENTAL DISEASE; MOLECULAR MECHANICS; MOTIVATION; MOTOR CONTROL; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; OPTOGENETICS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; REWARD; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

DORSAL STRIATUM; DSTR; FAST SPIKING INTERNEURON; FS; LOW THRESHOLD SPIKING INTERNEURON; LTS; MEDIUM SPINY NEURON; MEDIUM SPINY NEURONS; MOTOR CONTROL; MSN; NAC; NUCLEUS ACCUMBENS; OPTOGENETICS; REWARD; SN; STRIATUM; SUBSTANTIA NIGRA; TAN; TONICALLY ACTIVE CHOLINERGIC INTERNEURON; TONICALLY ACTIVE CHOLINERGIC INTERNEURONS; VENTRAL TEGMENTAL AREA; VTA;

ANIMALS; BRAIN MAPPING; CORPUS STRIATUM; INTERNEURONS; NEURONS; NEURONS, AFFERENT; OPTOGENETICS; REWARD; SIGNAL TRANSDUCTION;

EID: 84884980216     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.04.018     Document Type: Review

References (137)

1. Deisseroth K., Feng G., Majewska A.K., Miesenbock G., Ting A., Schnitzer M.J. Next-generation optical technologies for illuminating genetically targeted brain circuits. Journal of Neuroscience 2006, 26:10380-10386. 10.1523/JNEUROSCI. 3863-06.2006.
2. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8:1263-1268. 10.1038/nn1525.
3. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34. 10.1016/j.neuron.2011.06.004.
4. Fenno L., Yizhar O., Deisseroth K. The development and application of optogenetics. Annual Review of Neuroscience 2011, 34:389-412. 10.1146/annurev-neuro-061010-113817.
5. Kravitz A.V., Kreitzer A.C. Optogenetic manipulation of neural circuitry in vivo. Current Opinion in Neurobiology 2011, 21:433-439. 10.1016/j.conb.2011.02.010.
6. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology 1996, 50:381-425. 10.1016/S0301-0082(96)00042-1.
7. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831. 10.1126/science.8091209.
8. Yin H.H., Knowlton B.J. The role of the basal ganglia in habit formation. Nature Reviews Neuroscience 2006, 7:464-476. 10.1038/nrn1919.
9. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59:1151-1159. 10.1016/j.biopsych.2005.09.018.
10. Lobo M.K., Nestler E.J. The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Frontiers in Neuroanatomy 2011, 5:41. 10.3389/fnana.2011.00041.
11. Graybiel A.M. The basal ganglia. Current Biology 2000, 10:R509-R511.
12. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554. 10.1016/j.neuron.2008.11.005.
13. Morris G., Arkadir D., Nevet A., Vaadia E., Bergman H. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 2004, 43:133-143. 10.1016/j.neuron.2004.06.012.
14. Aosaki T., Tsubokawa H., Ishida A., Watanabe K., Graybiel A.M., Kimura M. Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. Journal of Neuroscience 1994, 14:3969-3984.
15. Bevan M.D., Booth P.A., Eaton S.A., Bolam J.P. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. Journal of Neuroscience 1998, 18:9438-9452.
16. Sidibe M., Smith Y. Thalamic inputs to striatal interneurons in monkeys: synaptic organization and co-localization of calcium binding proteins. Neuroscience 1999, 89:1189-1208.
17. Lapper S.R., Smith Y., Sadikot A.F., Parent A., Bolam J.P. Cortical input to parvalbumin-immunoreactive neurones in the putamen of the squirrel monkey. Brain Research 1992, 580:215-224.
18. Bennett B.D., Bolam J.P. Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat. Neuroscience 1994, 62:707-719.
19. Tepper J., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Current Opinion in Neurobiology 2004, 14:685-692. 10.1016/j.conb.2004.10.003.
20. Chesselet M.F., Graybiel A.M. Striatal neurons expressing somatostatin-like immunoreactivity: evidence for a peptidergic interneuronal system in the cat. Neuroscience 1986, 17:547-571.
21. Kubota Y., Inagaki S., Kito S., Shimada S., Okayama T., Hatanaka H., et al. Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat neostriatum. Brain Research 1988, 458:389-393.
22. Smith Y., Parent A. Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 1986, 18:347-371.
23. Vincent S.R., Johansson O., Hokfelt T., Skirboll L., Elde R.P., Terenius L., et al. NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. Journal of Comparative Neurology 1983, 217:252-263. 10.1002/cne.902170303.
24. Calabresi P., Gubellini P., Centonze D., Sancesario G., Morello M., Giorgi M., et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. Journal of Neuroscience 1999, 19:2489-2499.
25. Vuillet J., Kerkerian L., Salin P., Nieoullon A. Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Research 1989, 477:241-251.
26. Kreitzer A. Physiology and pharmacology of striatal neurons. Annual Review of Neuroscience 2009, 32:127-147. 10.1146/annurev.neuro.051508.135422.
27. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends in Neurosciences 1992, 15:133-139. 10.1016/0166-2236(92)90355-C.
28. Gong S., Zheng C., Doughty M.L., Losos K., Didkovsky N., Schambra U.B., et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 2003, 425:917-925. 10.1038/nature02033.
29. http://www.genstat.org/.
30. Nicola S.M. The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology 2007, 191:521-550. 10.1007/s00213-006-0510-4.
31. Kawaguchi Y. Neostriatal cell subtypes and their functional roles. Neuroscience Research 1997, 27:1-8.
32. Lobo M.K., Karsten S.L., Gray M., Geschwind D.H., Yang X.W. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nature Neuroscience 2006, 9:443-452. 10.1038/nn1654.
33. Heiman M., Schaefer A., Gong S., Peterson J.D., Day M., Ramsey K.E., et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 2008, 135:738-748. 10.1016/j.cell.2008.10.028.
34. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 1984, 311:461-464.
35. Johnston J.G., Gerfen C.R., Haber S.N., van der Kooy D. Mechanisms of striatal pattern formation: conservation of mammalian compartmentalization. Brain Research. Developmental Brain Research 1990, 57:93-102.
36. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873. 10.1016/j.neuron.2012.03.017.
37. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000, 96:451-474.
38. Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. Journal of Neurophysiology 2000, 84:1422-1429.
39. McGeorge A.J., Faull R.L. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 1989, 29:503-537.
40. Groenewegen H.J., Wright C.I., Beijer A.V., Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Annals of the New York Academy of Sciences 1999, 877:49-63.
41. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989, 12:366-375.
42. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. Journal of Anatomy 2000, 196(Pt 4):527-542.
43. Gong S., Yang X.W., Li C., Heintz N. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication. Genome Research 2002, 12:1992-1998. 10.1101/gr.476202.
44. Yang X.W., Gong S. An overview on the generation of BAC transgenic mice for neuroscience research. Current protocols in neuroscience 2005, Chapter 5:Unit 5.20-Unit 5.20. 10.1002/0471142301.ns0520s31.
45. Lemberger T., Parlato R., Dassesse D., Westphal M., Casanova E., Turiault M., et al. Expression of Cre recombinase in dopaminoceptive neurons. BMC Neuroscience 2007, 8:4. 10.1186/1471-2202-8-4.
46. Shuen J.A., Chen M., Gloss B., Calakos N. Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. Journal of Neuroscience 2008, 28:2681-2685. 10.1523/JNEUROSCI. 5492-07.2008.
47. Witten I., Steinberg E., Lee S., Davidson T., Zalocusky K., Brodsky M., et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 2011, 72:721-733. 10.1016/j.neuron.2011.10.028.
48. Zhao S., Ting J.T., Atallah H.E., Qiu L., Tan J., Gloss B., et al. Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nature Methods 2011, 8:745-752.
49. Lobo M.K., Covington H.E., Chaudhury D., Friedman A.K., Sun H., Damez-Werno D., et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010, 330:385-390. 10.1126/science.1188472.
50. Kravitz A.V., Freeze B.S., Parker P.R., Kay K., Thwin M.T., Deisseroth K., et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626. 10.1038/nature09159.
51. Witten I.B., Lin S., Brodsky M., Prakash R., Diester I., Anikeeva P., et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010, 330:1677-1681. 10.1126/science.1193771.
52. Lobo M.K., Cui Y., Ostlund S.B., Balleine B.W., Yang X.W. Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. Nature Neuroscience 2007, 10:1395-1397. 10.1038/nn1987.
53. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647. 10.1038/nature05506.
54. Gong S., Doughty M., Harbaugh C.R., Cummins A., Hatten M.E., Heintz N., et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. Journal of Neuroscience 2007, 27:9817-9823. 10.1523/JNEUROSCI. 2707-07.2007.
55. Cardin J.A., Carlen M., Meletis K., Knoblich U., Zhang F., Deisseroth K., et al. Targeted optogenetic stimulation and recording of neurons in vivo using cell-type-specific expression of Channelrhodopsin-2. Nature Protocols 2010, 5:247-254. 10.1038/nprot.2009.228.
56. Tsai H.C., Zhang F., Adamantidis A., Stuber G.D., Bonci A., de Lecea L., et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009, 324:1080-1084. 10.1126/science.1168878.
57. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends in Neurosciences 1990, 13:281-285.
58. Penney J.B., Young A.B. Striatal inhomogeneities and basal ganglia function. Movement Disorders 1986, 1:3-15. 10.1002/mds.870010102.
59. Hikida T., Kimura K., Wada N., Funabiki K., Nakanishi S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010, 66:896-907. 10.1016/j.neuron.2010.05.011.
60. Durieux P.F., Bearzatto B., Guiducci S., Buch T., Waisman A., Zoli M., et al. D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nature Neuroscience 2009, 12:393-395. 10.1038/nn.2286.
61. Durieux P.F., Schiffmann S.N., de Kerchove d'Exaerde A. Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions. EMBO Journal 2011, 31:640-653. 10.1038/emboj.2011.400.
62. Robertson H.A., Paul M.L., Moratalla R., Graybiel A.M. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Canadian Journal of Neurological Sciences 1991, 18:380-383.
63. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:1291-1295.
64. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. Journal of Neurophysiology 1992, 68:767-777.
65. Cenci M.A., Campbell K., Wictorin K., Bjorklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. European Journal of Neuroscience 1992, 4:376-380.
66. Kelz M.B., Chen J., Carlezon W.A., Whisler K., Gilden L., Beckmann A.M., et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 1999, 401:272-276. 10.1038/45790.
67. Werme M., Messer C., Olson L., Gilden L., Thoren P., Nestler E.J., et al. Delta FosB regulates wheel running. Journal of Neuroscience 2002, 22:8133-8138.
68. Zachariou V., Bolanos C.A., Selley D.E., Theobald D., Cassidy M.P., Kelz M.B., et al. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nature Neuroscience 2006, 9:205-211. 10.1038/nn1636.
69. Vialou V., Robison A.J., Laplant Q.C., Covington H.E., Dietz D.M., Ohnishi Y.N., et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nature Neuroscience 2010, 13:745-752. 10.1038/nn.2551.
70. Grueter B.A., Robison A.J., Neve R.L., Nestler E.J., Malenka R.C. FosB differentially modulates nucleus accumbens direct and indirect pathway function. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:1923-1928. 10.1073/pnas.1221742110.
71. Stefanik M.T., Moussawi K., Kupchik Y.M., Smith K.C., Miller R.L., Huff M.L., et al. Optogenetic inhibition of cocaine seeking in rats. Addiction Biology 2012, 10.1111/j. 1369-1600.2012.00479.x.
72. Koya E., Golden S.A., Harvey B.K., Guez-Barber D.H., Berkow A., Simmons D.E., et al. Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization. Nature Neuroscience 2009, 12:1069-1073. 10.1038/nn.2364.
73. Ferguson S.M., Eskenazi D., Ishikawa M., Wanat M.J., Phillips P.E., Dong Y., et al. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nature Neuroscience 2011, 14:22-24. 10.1038/nn.2703.
74. Tai L.H., Lee A.M., Benavidez N., Bonci A., Wilbrecht L. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nature Neuroscience 2012, 15:1281-1289. 10.1038/nn.3188.
75. Kravitz A.V., Tye L.D., Kreitzer A.C. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nature Neuroscience 2012, 3100. doi: 10. 1038/nn. 3100.
76. Chuhma N., Tanaka K.F., Hen R., Rayport S. Functional connectome of the striatal medium spiny neuron. Journal of Neuroscience 2011, 31:1183-1192. 10.1523/JNEUROSCI. 3833-10.2011.
77. Xia Y., Driscoll J.R., Wilbrecht L., Margolis E.B., Fields H.L., Hjelmstad G.O. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. Journal of Neuroscience 2011, 31:7811-7816. 10.1523/JNEUROSCI. 1504-11.2011.
78. Thanos P.K., Robison L., Nestler E.J., Kim R., Michaelides M., Lobo M., et al. Mapping brain metabolic connectivity in awake rats with microPET and optogenetic stimulation. Journal of Neuroscience 2013, Epub April 10, 2013.
79. Furey M.L., Pietrini P., Haxby J.V., Drevets W.C. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 2008, 33:913-923. 10.1038/sj.npp.1301461.
80. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nature Neuroscience 2003, 6:51-58. 10.1038/nn992.
81. Williams M.J., Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008, 33:1779-1797. 10.1038/sj.npp.1301585.
82. Apicella P. Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events. European Journal of Neuroscience 2002, 16:2017-2026.
83. Kravitz A., Kreitzer A. Striatal mechanisms underlying movement, reinforcement, and punishment. Physiology 2012, 27:167-177. 10.1152/physiol.00004.2012.
84. Higley M.J., Gittis A.H., Oldenburg I.A., Balthasar N., Seal R.P., Edwards R.H., et al. Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum. PLoS One 2011, 6:e19155. 10.1371/journal.pone.0019155.
85. English D.F., Ibanez-Sandoval O., Stark E., Tecuapetla F., Buzsaki G., Deisseroth K., et al. GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons. Nature Neuroscience 2011, 15:123-130. 10.1038/nn.2984.
86. Joshua M., Adler A., Mitelman R., Vaadia E., Bergman H. Midbrain dopaminergic neurons and striatal cholinergic interneurons encode the difference between reward and aversive events at different epochs of probabilistic classical conditioning trials. Journal of Neuroscience 2008, 28:11673-11684. 10.1523/JNEUROSCI. 3839-08.2008.
87. Threlfell S., Lalic T., Platt N., Jennings K., Deisseroth K., Cragg S. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 2012, 75:58-64. 10.1016/j.neuron.2012.04.038.
88. Cachope R., Mateo Y., Mathur B.N., Irving J., Wang H.L., Morales M., et al. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Reports 2012, 2:33-41. 10.1016/j.celrep.2012.05.011.
89. Szydlowski S.N., Pollak Dorocic I., Planert H., Carlen M., Meletis K., Silberberg G. Target selectivity of feedforward inhibition by striatal fast-spiking interneurons. Journal of Neuroscience 2013, 33:1678-1683. 10.1523/JNEUROSCI. 3572-12.2013.
90. Schultz W. Predictive reward signal of dopamine neurons. Journal of Neurophysiology 1998, 80:1-27.
91. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry 2005, 162:1403-1413. 10.1176/appi.ajp.162.8.1403.
92. Gerfen C.R., Surmeier D.J. Modulation of striatal projection systems by dopamine. Annual Review of Neuroscience 2011, 34:441-466. 10.1146/annurev-neuro-061010-113641.
93. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. Journal of Neuroscience 1984, 4:2877-2890.
94. Wise R.A. Addictive drugs and brain stimulation reward. Annual Review of Neuroscience 1996, 19:319-340. 10.1146/annurev.ne.19.030196.001535.
95. Adamantidis A.R., Tsai H.C., Boutrel B., Zhang F., Stuber G.D., Budygin E.A., et al. Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. Journal of Neuroscience 2011, 31:10829-10835. 10.1523/JNEUROSCI. 2246-11.2011.
96. Lammel S., Ion D.I., Roeper J., Malenka R.C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 2011, 70:855-862. 10.1016/j.neuron.2011.03.025.
97. Koo J.W., Mazei-Robison M.S., Chaudhury D., Juarez B., LaPlant Q., Ferguson D., et al. BDNF is a negative modulator of morphine action. Science 2012, 338(6103):124-128. 10.1126/science.1222265.
98. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868. 10.1126/science.1120972.
99. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 2006, 9:519-525. 10.1038/nn1659.
100. Chaudhury D., Walsh J.J., Friedman A.K., Juarez B., Ku S.M., Koo J.W., Ferguson D., Tsai H.C., Pomeranz L., Christoffel D.J., Nectow A.R., Ekstrand M., Domingos A., Mazie-Robison M., Mouzon E., Lobo M.K., Neve R.L., Friedman J.M., Russo S.J., Deisseroth K., Nestler E.J., Han M.H. Rapid regulation of depression-related behaviors by control of midbrain dopamine neurons. Nature 2013, 493:532-536. 10.1038/nature11713.
101. Tye K.M., Mirzabekov J.J., Warden M.R., Ferenczi E.A., Tsai H.C., Finkelstein J., et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2012, 10.1038/nature11740; 10.1038/nature11740.
102. Valenti O., Gill K.M., Grace A.A. Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: response alteration by stress pre-exposure. European Journal of Neuroscience 2012, 35:1312-1321. 10.1111/j. 1460-9568.2012.08038.x.
103. Bass C.E., Grinevich V.P., Vance Z.B., Sullivan R.P., Bonin K.D., Budygin E.A. Optogenetic control of striatal dopamine release in rats. Journal of Neurochemistry 2010, 114:1344-1352. 10.1111/j. 1471-4159.2010.06850.x.
104. Bass C.E., Grinevich V.P., Kulikova A.D., Bonin K.D., Budygin E.A. Terminal effects of optogenetic stimulation on dopamine dynamics in rat striatum. Journal of Neuroscience Methods 2013, 214:149-155. 10.1016/j.jneumeth.2013.01.024.
105. van Zessen R., Phillips J.L., Budygin E.A., Stuber G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 2012, 73:1184-1194. 10.1016/j.neuron.2012.02.016.
106. Tan K.R., Yvon C., Turiault M., Mirzabekov J.J., Doehner J., Labouebe G., et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012, 73:1173-1183. 10.1016/j.neuron.2012.02.015.
107. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217. 10.1038/nature11527.
108. Stuber G.D., Sparta D.R., Stamatakis A.M., van Leeuwen W.A., Hardjoprajitno J.E., Cho S., et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 2011, 475:377-380. 10.1038/nature10194.
109. Britt J.P., Benaliouad F., McDevitt R.A., Stuber G.D., Wise R.A., Bonci A. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 2012, 76:790-803. 10.1016/j.neuron.2012.09.040.
110. Suska A., Lee B.R., Huang Y.H., Dong Y., Schluter O.M. Selective presynaptic enhancement of the prefrontal cortex to nucleus accumbens pathway by cocaine. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:713-718. 10.1073/pnas.1206287110.
111. MacAskill A.F., Little J.P., Cassel J.M., Carter A.G. Subcellular connectivity underlies pathway-specific signaling in the nucleus accumbens. Nature Neuroscience 2012, 15:1624-1626. 10.1038/nn.3254.
112. Covington H.E., Lobo M.K., Maze I., Vialou V., Hyman J.M., Zaman S., et al. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. Journal of Neuroscience 2010, 30:16082-16090. 10.1523/JNEUROSCI. 1731-10.2010.
113. Kumar S., Black S.J., Hultman R., Szabo S.T., DeMaio K.D., Du J., et al. Cortical control of affective networks. Journal of Neuroscience 2013, 33:1116-1129. 10.1523/JNEUROSCI. 0092-12.2013.
114. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660. 10.1016/j.neuron.2005.02.014.
115. Airan R.D., Thompson K.R., Fenno L.E., Bernstein H., Deisseroth K. Temporally precise in vivo control of intracellular signalling. Nature 2009, 458:1025-1029. 10.1038/nature07926.
116. Dietz D.M., Sun H., Lobo M.K., Cahill M.E., Chadwick B., Gao V., et al. Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons. Nature Neuroscience 2012, 10.1038/nn.3094.
117. Wu Y.I., Wang X., He L., Montell D., Hahn K.M. Spatiotemporal control of small GTPases with light using the LOV domain. Methods in Enzymology 2011, 497:393-407. 10.1016/B978-0-12-385075-1. 00016-0.
118. Wu Y.I., Frey D., Lungu O.I., Jaehrig A., Schlichting I., Kuhlman B., et al. A genetically encoded photoactivatable Rac controls the motility of living cells. Nature 2009, 461:104-108. 10.1038/nature08241.
119. Hahn K.M., Kuhlman B. Hold me tightly LOV. Nature Methods 2010, 7:595-597. 10.1038/nmeth0810-595.
120. Oh E., Maejima T., Liu C., Deneris E., Herlitze S. Substitution of 5-HT1A receptor signaling by a light-activated G protein-coupled receptor. Journal of Biological Chemistry 2010, 285:30825-30836. 10.1074/jbc.M110.147298.
121. Ryu M.H., Moskvin O.V., Siltberg-Liberles J., Gomelsky M. Natural and engineered photoactivated nucleotidyl cyclases for optogenetic applications. Journal of Biological Chemistry 2010, 285:41501-41508. 10.1074/jbc.M110.177600.
122. Stierl M., Stumpf P., Udwari D., Gueta R., Hagedorn R., Losi A., et al. Light modulation of cellular cAMP by a small bacterial photoactivated adenylyl cyclase, bPAC, of the soil bacterium Beggiatoa. Journal of Biological Chemistry 2011, 286:1181-1188. 10.1074/jbc.M110.185496.
123. Girault J. Integrating neurotransmission in striatal medium spiny neurons. Advances in Experimental Medicine and Biology 2012, 970:407-429. 10.1007/978-3-7091-0932-8_18.
124. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neuroscience 1999, 2:358-363. doi: 10. 1038/7268.
125. Kravitz A.V., Owen S.F., Kreitzer A.C. Optogenetic identification of striatal projection neuron subtypes during in vivo recordings. Brain Research 2012, 10.1016/j.brainres.2012.11.018.
126. Cui G., Jun S.B., Jin X., Pham M.D., Vogel S.S., Lovinger D.M., et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 2013, 494:238-242. 10.1038/nature11846.
127. Fowler C.D., Kenny P.J. Utility of genetically modified mice for understanding the neurobiology of substance use disorders. Human Genetics 2012, 131:941-957. 10.1007/s00439-011-1129-z.
128. Briand L.A., Lee F.S., Blendy J.A., Pierce R.C. Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice. European Journal of Neuroscience 2012, 35:932-939. 10.1111/j. 1460-9568.2012.08021.x.
129. Ruiz-Durantez E., Hall S.K., Steffen C., Self D.W. Enhanced acquisition of cocaine self-administration by increasing percentages of C57BL/6J genes in mice with a nonpreferring outbred background. Psychopharmacology 2006, 186:553-560. 10.1007/s00213-006-0379-2.
130. Cavanaugh J., Monosov I.E., McAlonan K., Berman R., Smith M.K., Cao V., et al. Optogenetic inactivation modifies monkey visuomotor behavior. Neuron 2012, 76:901-907. 10.1016/j.neuron.2012.10.016.
131. Galvan A., Hu X., Smith Y., Wichmann T. In vivo optogenetic control of striatal and thalamic neurons in non-human primates. PLoS One 2012, 7:e50808. 10.1371/journal.pone.0050808.
132. Bewernick B.H., Kayser S., Sturm V., Schlaepfer T.E. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012, 37:1975-1985. 10.1038/npp.2012.44.
133. Bourne S.K., Eckhardt C.A., Sheth S.A., Eskandar E.N. Mechanisms of deep brain stimulation for obsessive compulsive disorder: effects upon cells and circuits. Frontiers in Integrative Neuroscience 2012, 6:29. 10.3389/fnint.2012.00029.
134. Niu L., Ji L.Y., Li J.M., Zhao D.S., Huang G., Liu W.P., et al. Effect of bilateral deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease. Journal of International Medical Research 2012, 40:1108-1113.
135. Viswanathan A., Jimenez-Shahed J., Baizabal Carvallo J.F., Jankovic J. Deep brain stimulation for tourette syndrome: target selection. Stereotactic and Functional Neurosurgery 2012, 90:213-224. 10. 1159/000337776.
136. Spielberger S., Hotter A., Wolf E., Eisner W., Muller J., Poewe W., et al. Deep brain stimulation in Huntington's disease: A 4-year follow-up case report. Movement Disorders 2012, 27:806-807. author reply 807-8. 10.1002/mds.24959.
137. Mattis J., Tye K.M., Ferenczi E.A., Ramakrishnan C., O'Shea D.J., Prakash R., et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nature Methods 2011, 9:159-172. 10.1038/nmeth.1808.